Synthace
Based in London, UK, Synthace is developing Antha, a language and software platform specifically for biology research. Antha is designed to make reproducible and scalable workflows that can be readily edited and shared, and easily automated on labs’ existing equipment.
In 2016, the World Economic Forum included Synthace in its selection of the world’s 30 most promising Technology Pioneers that are helping shape the Fourth Industrial Revolution – a technological revolution that will fundamentally alter the way we live, work and relate to one another.
Amadeus contact
In the media
21st October 2019
Building a Community to Change Biology for the Better
Forward-thinking companies like Synthace are trying to help biologists overcome these challenges by giving them a software solution that can empower them to do more sophisticated science, faster. Another way they
18th October 2019
Industrial Revolution: the end of oil and the rise of the biological economy
Taking the example of the companies Arzeda, Zymergen and Synthace, which Bioeconomy Capital invests in, these companies can design, build and optimize new metabolic pathways to directly produce any molecule from
16th October 2019
NanoRobotics Market is expected to reach $11.88 Billion by 2026 growing at a CAGR of 12.5% during the forecast period
Nanorobotics include Bruker, JEOL, Thermo Fisher Scientific, Ginkgo Bioworks, Oxford Instruments, EV Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik, Xidex, Synthace, Park Systems, Smaract and Nanonics Imaging